Lucid Diagnostics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LUCD and other ETFs, options, and stocks.About LUCD
Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma.
LUCD Key Statistics
Stock Snapshot
As of today, Lucid Diagnostics(LUCD) shares are valued at $1.45. The company's market cap stands at 190.75M, with a P/E ratio of -1.61.
On 2026-03-02, Lucid Diagnostics(LUCD) stock traded between a low of $1.37 and a high of $1.46. Shares are currently priced at $1.45, which is +5.8% above the low and -0.7% below the high.
The Lucid Diagnostics(LUCD)'s current trading volume is 913.89K, compared to an average daily volume of 872.23K.
During the past year, Lucid Diagnostics(LUCD) stock moved between $0.95 at its lowest and $1.80 at its peak.
During the past year, Lucid Diagnostics(LUCD) stock moved between $0.95 at its lowest and $1.80 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.